127 related articles for article (PubMed ID: 22573404)
1. Inhibition of PAI-1 induces neutrophil-driven neoangiogenesis and promotes tissue regeneration via production of angiocrine factors in mice.
Tashiro Y; Nishida C; Sato-Kusubata K; Ohki-Koizumi M; Ishihara M; Sato A; Gritli I; Komiyama H; Sato Y; Dan T; Miyata T; Okumura K; Tomiki Y; Sakamoto K; Nakauchi H; Heissig B; Hattori K
Blood; 2012 Jun; 119(26):6382-93. PubMed ID: 22573404
[TBL] [Abstract][Full Text] [Related]
2. Tissue type plasminogen activator regulates myeloid-cell dependent neoangiogenesis during tissue regeneration.
Ohki M; Ohki Y; Ishihara M; Nishida C; Tashiro Y; Akiyama H; Komiyama H; Lund LR; Nitta A; Yamada K; Zhu Z; Ogawa H; Yagita H; Okumura K; Nakauchi H; Werb Z; Heissig B; Hattori K
Blood; 2010 May; 115(21):4302-12. PubMed ID: 20110420
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor-1 regulates macrophage-dependent postoperative adhesion by enhancing EGF-HER1 signaling in mice.
Honjo K; Munakata S; Tashiro Y; Salama Y; Shimazu H; Eiamboonsert S; Dhahri D; Ichimura A; Dan T; Miyata T; Takeda K; Sakamoto K; Hattori K; Heissig B
FASEB J; 2017 Jun; 31(6):2625-2637. PubMed ID: 28270519
[TBL] [Abstract][Full Text] [Related]
4. Role of neutrophil-derived matrix metalloproteinase-9 in tissue regeneration.
Heissig B; Nishida C; Tashiro Y; Sato Y; Ishihara M; Ohki M; Gritli I; Rosenkvist J; Hattori K
Histol Histopathol; 2010 Jun; 25(6):765-70. PubMed ID: 20376783
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of plasminogen activator inhibitor type-1 activity enhances rapid and sustainable hematopoietic regeneration.
Ibrahim AA; Yahata T; Onizuka M; Dan T; Van Ypersele De Strihou C; Miyata T; Ando K
Stem Cells; 2014 Apr; 32(4):946-58. PubMed ID: 24155177
[TBL] [Abstract][Full Text] [Related]
6. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
[TBL] [Abstract][Full Text] [Related]
7. Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis.
Brodsky S; Chen J; Lee A; Akassoglou K; Norman J; Goligorsky MS
Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1784-92. PubMed ID: 11557572
[TBL] [Abstract][Full Text] [Related]
8. The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent.
Devy L; Blacher S; Grignet-Debrus C; Bajou K; Masson V; Gerard RD; Gils A; Carmeliet G; Carmeliet P; Declerck PJ; Nöel A; Foidart JM
FASEB J; 2002 Feb; 16(2):147-54. PubMed ID: 11818362
[TBL] [Abstract][Full Text] [Related]
9. A novel inhibitor of plasminogen activator inhibitor-1 provides antithrombotic benefits devoid of bleeding effect in nonhuman primates.
Izuhara Y; Yamaoka N; Kodama H; Dan T; Takizawa S; Hirayama N; Meguro K; van Ypersele de Strihou C; Miyata T
J Cereb Blood Flow Metab; 2010 May; 30(5):904-12. PubMed ID: 20087372
[TBL] [Abstract][Full Text] [Related]
10. Genetic deficiency of plasminogen activator inhibitor-1 promotes cardiac fibrosis in aged mice: involvement of constitutive transforming growth factor-beta signaling and endothelial-to-mesenchymal transition.
Ghosh AK; Bradham WS; Gleaves LA; De Taeye B; Murphy SB; Covington JW; Vaughan DE
Circulation; 2010 Sep; 122(12):1200-9. PubMed ID: 20823384
[TBL] [Abstract][Full Text] [Related]
11. A novel plasminogen activator inhibitor-1 inhibitor, TM5441, protects against high-fat diet-induced obesity and adipocyte injury in mice.
Piao L; Jung I; Huh JY; Miyata T; Ha H
Br J Pharmacol; 2016 Sep; 173(17):2622-32. PubMed ID: 27339909
[TBL] [Abstract][Full Text] [Related]
12. Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice.
Ahn MY; Zhang ZG; Tsang W; Chopp M
Brain Res; 1999 Aug; 837(1-2):169-76. PubMed ID: 10433999
[TBL] [Abstract][Full Text] [Related]
13. VEGF-A recruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissue.
Christoffersson G; Vågesjö E; Vandooren J; Lidén M; Massena S; Reinert RB; Brissova M; Powers AC; Opdenakker G; Phillipson M
Blood; 2012 Nov; 120(23):4653-62. PubMed ID: 22966168
[TBL] [Abstract][Full Text] [Related]
14. CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A.
Scapini P; Morini M; Tecchio C; Minghelli S; Di Carlo E; Tanghetti E; Albini A; Lowell C; Berton G; Noonan DM; Cassatella MA
J Immunol; 2004 Apr; 172(8):5034-40. PubMed ID: 15067085
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of plasminogen activator inhibitor-1 restores skeletal muscle regeneration in untreated type 1 diabetic mice.
Krause MP; Moradi J; Nissar AA; Riddell MC; Hawke TJ
Diabetes; 2011 Jul; 60(7):1964-72. PubMed ID: 21593201
[TBL] [Abstract][Full Text] [Related]
16. [Plasminogen activator inhibitor-1 (PAI-1) molecule: new physiological roles and clinical applications].
Dan T; Ichimura A; Pelisch N; Miyata K; Akahori K; Miyata T
Rinsho Ketsueki; 2014 Apr; 55(4):396-404. PubMed ID: 24850450
[No Abstract] [Full Text] [Related]
17. The role of the fibrinolytic system in corneal angiogenesis.
Vogten JM; Reijerkerk A; Meijers JC; Voest EE; Borel Rinkes IH; Gebbink MF
Angiogenesis; 2003; 6(4):311-6. PubMed ID: 15166500
[TBL] [Abstract][Full Text] [Related]
18. Reduced monocyte adhesion to aortae of diabetic plasminogen activator inhibitor-1 knockout mice.
Zhao R; Le K; Moghadasian MH; Shen GX
Inflamm Res; 2017 Sep; 66(9):783-792. PubMed ID: 28550522
[TBL] [Abstract][Full Text] [Related]
19. A small molecule inhibitor of PAI-1 protects against doxorubicin-induced cellular senescence.
Ghosh AK; Rai R; Park KE; Eren M; Miyata T; Wilsbacher LD; Vaughan DE
Oncotarget; 2016 Nov; 7(45):72443-72457. PubMed ID: 27736799
[TBL] [Abstract][Full Text] [Related]
20. Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment.
Deryugina EI; Zajac E; Juncker-Jensen A; Kupriyanova TA; Welter L; Quigley JP
Neoplasia; 2014 Oct; 16(10):771-88. PubMed ID: 25379015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
